Delivery Order SPE2DB22D2211-SPE2DB24FNSJ3
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,261.06 firm fixed-price delivery order is for the supply of 100 tablets of 54 mg Methylphenidate ER, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,503.22 firm-fixed-price delivery order is for the supply of 4,566,436 units of Methylphenidate ER 36 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award has an ultimate completion date of November 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,116.98 firm fixed-price delivery order is for the supply of 4,567,786,336 tablets of Methylphenidate ER 36 mg, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,603.12 Firm Fixed Price delivery order contract is for the supply of Methylphenidate ER 18 mg tablets, a medication used to treat ADHD. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,168.40 Firm Fixed Price Delivery Order contract is for the supply of Methylphenidate ER 27 mg tablets, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract has an ultimate completion date of November 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,710.36 firm fixed-price delivery order is for the supply of 4,566,250 units of methylphenidate ER 36 mg tablets, a medication commonly used to treat attention deficit hyperactivity disorder (ADHD). The contract has an ultimate completion date of October 29, 2024 and was awarded on October 28, 2024. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,877.16 delivery order is for the supply of Methylphenidate ER 36 mg tablets, a generic prescription medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,025.46 firm fixed-price delivery order is for the supply of 100 count tablets of 27 mg methylphenidate extended-release, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 9, 2024. AmerisourceBergen holds a $999,999,999...
- This federal contract award, valued at $1,012.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the provision of 4567944679 - Methylphenidate ER 36 mg tablets, a neurological medication. The contract has a firm fixed price and an ultimate completion date of April 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,402.42 firm-fixed-price delivery order is for the supply of 4,566,676,427 units of the drug Methylphenidate ER 36 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of December 11, 2024 and was awarded on December 10, 2024. It is...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FNSJ3Delivery Order
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,282.16 firm fixed-price delivery order is for the supply of 4564882038 - Methylphenidate ER 36 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award has an ultimate completion date of June 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order falls under that broader IDC. The contract award was not designated with any set-aside requirements, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 6/12/24 |